AG
STDY

Advisor Group’s SteadyMed Ltd STDY Stock Holding History

Advisor Group’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-500
Closed -$3K – 5052
2017
Q2 		$3K Sell
500
-900
-64% -$6.12K ﹤0.01% 4465
2017
Q1 		$8K Buy
+1,400
New +$4.67K ﹤0.01% 3936

Other funds holding STDY

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Advisor Group's STDY Position: Q3 2017 in Review

Advisor Group sold out of SteadyMed Ltd (STDY) in Q3 2017, closing a stake of 500 shares — an estimated $3K sold.

Advisor Group first reported a position in STDY in Q1 2017 and held it in 2 quarters. The position peaked at $8K in Q1 2017. 26 funds tracked by Wall St. Rank hold STDY as of Q3 2017.

  • Advisor Group reported no remaining SteadyMed Ltd position as of Q3 2017 after selling out during the quarter.
  • Advisor Group sold 500 SteadyMed Ltd shares in Q3 2017, an estimated $3K.
  • Advisor Group first reported a position in SteadyMed Ltd in Q1 2017 and held it in 2 quarters.
  • Advisor Group's SteadyMed Ltd position peaked at $8K in Q1 2017.
  • 26 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2017.

Based on Advisor Group's 13F filing for Q3 2017, filed 6 Nov 2017.